New antibiotic agents and approaches to treat biofilm-associated infections

Expert Opinion on Therapeutic Patents
A Simon Lynch, Darren Abbanat

Abstract

Current antibiotics have classically been developed to treat infections involving planktonic bacterial populations in acute infection settings and are typically ineffective in the eradication of bacteria in biofilm-associated, persistent infections. The paucity of effective current treatment options and the growing population of susceptible patients with indwelling medical devices and materials are key factors that substantiate the need for new agents effective in the prevention or eradication of biofilms. Published patents relating to biofilm-active agents were identified in SciFinder(®) for the period January 2005 through March 2010 and representative patents selected with an emphasis on agents claimed for the prophylaxis or treatment of bacterial biofilm infections. The review provides a basic understanding of the medical challenges posed by biofilm-associated infections, and summarizes claims describing novel therapeutic approaches in the management of biofilm infections. Treatment of biofilm-associated infections with existing approved therapies remains a significant medical challenge. In the near term, new agents demonstrating bactericidal activity against bacteria within biofilms will be most readily incorporated into ex...Continue Reading

References

May 19, 2000·Antimicrobial Agents and Chemotherapy·C Torres-VieraG M Eliopoulos
Jun 24, 2000·Microbes and Infection·R A Burne, Y Y Chen
Feb 15, 2001·Acta Crystallographica. Section D, Biological Crystallography·K H VerschuerenA J Wilkinson
Apr 3, 2001·Current Opinion in Microbiology·R G Martin, J L Rosner
Apr 5, 2002·Clinical Microbiology Reviews·Rodney M Donlan, J William Costerton
Apr 12, 2002·Chembiochem : a European Journal of Chemical Biology·A SvenssonJ Kihlberg
Jun 13, 2002·Il Farmaco·Frederic ZentzDanielle Sirot
Jul 16, 2002·Infection and Immunity·Tomás Maira-LitránGerald B Pier
Sep 17, 2003·Oral Diseases·P C Baehni, Y Takeuchi
Oct 7, 2003·Annual Review of Microbiology·Matthew R Parsek, Pradeep K Singh
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Niels Høiby
Oct 19, 2004·Medical Hypotheses·E D Weinberg
Jun 14, 2005·Research in Microbiology·Rob Van Houdt, Chris W Michiels
Jul 8, 2005·Applied and Environmental Microbiology·Dacheng RenThomas K Wood
Oct 11, 2005·Annual Review of Cell and Developmental Biology·Christopher M Waters, Bonnie L Bassler
Jul 25, 2006·The Journal of Clinical Investigation·Grace SoongAlice Prince
Aug 29, 2006·Chemical Society Reviews·Evan M Hetrick, Mark H Schoenfisch
Oct 20, 2006·Journal of Bacteriology·Nicolas BarraudJeremy S Webb
Mar 17, 2007·The Journal of Clinical Investigation·Yukihiro KanekoPradeep K Singh
May 8, 2007·Annual Review of Microbiology·Rita TamayoAndrew Camilli
May 16, 2007·Molecular Microbiology·Andrea G O ManettiImmaculada Margarit
Aug 7, 2007·Journal of Bacteriology·Hans-Curt FlemmingDaniel J Wozniak
Sep 18, 2007·International Journal of Antimicrobial Agents·Riccardo UtiliMarie-Françoise Tripodi
Oct 17, 2007·Annual Review of Medicine·A Simon Lynch, Gregory T Robertson
Oct 27, 2007·Chemistry & Biology·Junguk ParkKim D Janda
Oct 29, 2008·Medicinal Research Reviews·Nanting NiBinghe Wang
Dec 3, 2008·Proceedings of the National Academy of Sciences of the United States of America·Deborah G ConradyAndrew B Herr
Dec 17, 2008·Journal of Bacteriology·David G Davies, Cláudia N H Marques
Jan 31, 2009·Journal of Biosciences·R Jayaraman
Feb 24, 2009·Biomaterials·Evan M HetrickMark H Schoenfisch
Jun 3, 2009·Microbiology and Molecular Biology Reviews : MMBR·Ece Karatan, Paula Watnick
Jul 15, 2009·Biotechnology and Applied Biochemistry·Sheetal RainaTajalli Keshavarz
Jul 23, 2009·Journal of the American Chemical Society·Steven A RogersChristian Melander
Sep 8, 2009·Expert Opinion on Therapeutic Patents·Jiachuan Pan, Dacheng Ren
Oct 2, 2009·FEMS Immunology and Medical Microbiology·Astha AgarwalAmita Jain
Nov 17, 2009·The Journal of Antimicrobial Chemotherapy·J R Samuel, F K Gould
Dec 19, 2009·PLoS Computational Biology·Michael E WallRobert G Martin
Feb 13, 2010·International Journal of Antimicrobial Agents·Niels HøibyOana Ciofu
Feb 19, 2010·Applied Microbiology and Biotechnology·Paolo LandiniReindert Nijland
Feb 20, 2010·FEMS Microbiology Letters·Yuka IshiharaMichio Ohta

❮ Previous
Next ❯

Citations

Nov 21, 2013·International Journal of Antimicrobial Agents·Darren AbbanatA Simon Lynch
Mar 1, 2012·Chemical Society Reviews·Alexis W Carpenter, Mark H Schoenfisch
Jul 22, 2011·Biofouling·Christian Traba, Jun F Liang
May 16, 2012·Antimicrobial Agents and Chemotherapy·Michael E ZegansJoseph S Lam
Sep 8, 2015·Pharmaceuticals·Philip S Stewart
Oct 24, 2012·European Journal of Medicinal Chemistry·Maria Valeria RaimondiGiuseppe Daidone
Oct 12, 2012·Annals of the New York Academy of Sciences·Domenico SchillaciVincenzo Arizza
May 1, 2012·Microbes and Infection·Uliana KomorSusanne Häussler
Apr 11, 2012·FEMS Immunology and Medical Microbiology·Stijn Chris Arnold RobijnsHans P L Steenackers
Jan 24, 2014·Pathogens and Disease·Pooi Y Chung, Yien S Toh
Apr 14, 2016·Journal of Bacteriology·Daniel Pletzer, Robert E W Hancock
Jan 14, 2011·Plastic and Reconstructive Surgery·Nalini RaoBenjamin A Lipsky
Jul 17, 2013·The Pediatric Infectious Disease Journal·Joshua WolfPatricia M Flynn
Jul 12, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anabela BorgesManuel Simões
Oct 21, 2020·Expert Opinion on Therapeutic Patents·Annalisa BiancheraRuggero Bettini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Related Papers

International Journal of Antimicrobial Agents
Niels HøibyOana Ciofu
FEMS Immunology and Medical Microbiology
Rebecca A BradyMark E Shirtliff
© 2021 Meta ULC. All rights reserved